pharmaphorum
MAY 9, 2022
SparkRx is designed to decrease depression in individuals aged 13 to 22 by providing a multi-week programme based on cognitive behavioural therapy (CBT) and behavioural activation protocols. “In In primary care, there are guidelines to screening for behavioural health concerns like depression annually. About the author .
pharmaphorum
DECEMBER 22, 2021
The 2022 intake companies are: Carium , which operates a telehealth platform – delivered via a patient app – that provides individualised care to patients from participating healthcare systems and links to a range of wearable devices; Clear Bill of Health (CBOH), which has developed as a COVID-19 vaccination and testing status facilitation tool; Culture (..)
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
APRIL 25, 2022
Gani started BehaVR in 2016 to create DTx for mental and behavioural health. He says after a meeting between him and a leader at Sumitomo in 2018 or 2019, it became apparent both companies believed in the power of VR in mental health care. Configuring a collaboration. About the author .
pharmaphorum
MARCH 21, 2022
In 2021, the behavioural health company and Sumitomo Dainippon Pharma Co. Jessica Hagen is a freelance life sciences and health writer and project manager who has worked with VR health companies, fiction/nonfiction authors, nonprofit and for-profit organisations, and government entities. About the author .
pharmaphorum
JANUARY 26, 2021
There is an opportunity to address this at scale with digital tools and techniques, and expand support into just about any therapeutic area through the holistic integration of mental and behavioural health solutions that improve patient care. We’re starting to see this happen through the emergence of smart homes and smart cars (i.e.,
pharmaphorum
JANUARY 27, 2022
Immersive technology can also help improve assessments of the effectiveness of treatment, particularly regarding behavioural health where a patient’s results are often subjective. Self-reporting can put patients in an awkward spot to adequately describe their feelings or thoughts, and this method can sometimes be unreliable.
Drug Discovery World
JANUARY 12, 2023
DDW learnt more about this in an interview with Mark Matson, Senior Solution Specialist for Sensor Cloud at Medidata, focussing on how the use of digital biomarkers in life sciences and how they can help advance our understanding of disease.
Expert insights. Personalized for you.
135 
Let's personalize your content